In this podcast from the 2018 PODD: Partnership Opportunities in Drug Delivery conference, Dr Christopher Kovalchick, Chief Engineer, Drug Delivery & Devices R&D Innovation at Eli Lilly and Company presented on incorporating of digital monitoring biomarkers into drug delivery.

More specifically a framework is presented which stratifies key components and advances the concept of contextualized biomarkers. The framework codifies how direct, indirect, composite and contextualized composite data can drive innovation for the application of digital biomarkers in healthcare. In addition, application in disease and wellness is highlighted and incorporation in clinical feedback loops and closed-loop systems is illustrated.

Dr Kovalchick is returning to PODD 2019 to present on Achieving the Ultimate Outcome for Patients- Utilizing Digital Health Data to Improve Disease Management, Prevention and Overall Wellness.

The 9th annual PODD conference with take place October 7-8, 2019 in Boston, MA. Learn more at theconferenceforum.org

The Role of Digital Biomarkers and the Impact on Drug Delivery

Share

Embed